News — APRIL 25, 2025, NEW YORK – Ludwig Cancer Research is proud to support eight early-career scientists presenting their research at the conference this year through the AACR Scholar-in-Training Awards (SITA) program, contributing to the cost of their travel and attendance at the conference. The SITA awards, the AACR notes, “recognize outstanding young investigators presenting meritorious proffered papers” at the meeting.
This year’s recipients are as follows:
Silver Alkhafaji, of University of California San Francisco will be presenting a poster titled: Serum immune markers are associated with pathological complete response and immune-related adverse events in immuno-oncology arms of the I-SPY2 breast cancer trial.
Session: Metastasis Biomarkers / Prognostic Biomarkers 1, Monday, April 28, 2025, 9:00 AM – 12:00 PM.
Mauricio Flores, of Roswell Park Comprehensive Cancer Center will be presenting a poster titled: RB1 and TP53 restrict lineage plasticity in prostate cancer by regulating chromatin accessibility.
Session: Cancer Cell Heterogeneity, Evolution, and Trajectory Profiling, Tuesday, April 29, 2025, 9:00 AM – 12:00 PM.
Esther Frimpong, of Florida A&M University College of Pharmacy and Pharmaceutical Sciences will be presenting a poster titled: Modified 5-FU immunoliposome targeting EGFR-expressing pancreatic tumors: In vitro and in vivo evaluation.
Session: Computational Drug Discovery, Nanotechnology, and Therapeutics, Tuesday, April 29, 2025, 9:00 AM – 12:00 PM.
Nadine Goldhammer, of University of California San Francisco will be presenting a poster titled: Changes in breast hormone signaling and inflammation underlie radiologic features of cancer risk.
Session: Biomarkers and Molecular Targets for Prevention, Monday, April 28, 2025, 9:00 AM – 12:00 PM.
Husain Khan, of Barbara Ann Karmanos Cancer Institute will be presenting a poster titled: Targeting XPO1 to enhance the durability of response of MRTX1133 in pancreatic ductal adenocarcinoma.
Session: Targeted Therapies and Combinations 4, Wednesday, April 30, 2025, 9:00 AM – 12:00 PM.
Swetha Nakshatri, of University of Chicago will be presenting a poster titled: Disparities in neurotoxicities in cisplatin-treated cancer patients: a population pharmacogenomics approach.
Session: Pharmacokinetics and Pharmacodynamics of Cancer Therapeutics, Tuesday, April 29, 2025, 9:00 AM – 12:00 PM.
Pablo Sanchis, of Conicet – Iquibicen will be presenting a poster titled: Fracturing the tumor-bone alliance in metastatic prostate cancer with Ra-223.
Session: Therapeutic Approaches to Attack the Tumor Microenvironment, Monday, April 28, 2025, 2:00 PM – 5:00 PM.
Barbara Sankofi, of University of Oklahoma Health Sciences Center will be presenting a poster titled: FGF1 regulates breast cancer growth and metabolic reprogramming through ETV4.
Session: Metabolic Reprogramming, Tuesday, April 29, 2025, 2:00 PM – 5:00 PM.
# # #
About Ludwig Cancer Research
Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 50 years. Ludwig combines basic science with the translation and clinical evaluation of its discoveries to accelerate the development of new cancer diagnostics, therapies and prevention strategies. Since 1971, Ludwig has invested nearly $3 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers. To learn more, visit .
For additional information please contact [email protected].
RSS